Neurology Journal,
This study provides Class I evidence that for mild to moderate acetylcholine receptor antibody-positive generalized myasthenia…
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis
Overview of attention for article published in Neurology, January 2022
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (93rd percentile)
-
Good Attention Score compared to outputs of the same age and source (72nd percentile)
Mentioned by
- blogs
- 1 blog
- policy
- 1 policy source
- 21 X users
- 1 Facebook page
- guideline
- 1 clinical guideline source
Readers on
- mendeley
- 103 Mendeley